“…Nonetheless, the reported values in these publications are similar to those obtained here. Our new findings suggest that a diffusible purinergic signal released by astrocytes themselves activates astroglial P2Y 1 R (i.e., astrocyte-to-astrocyte signaling) and upregulates the incidence of STs, which is supported by several evidences: (i) TTX-insensitive neurotransmitter release is associated with FTs confined to microdomains in astrocytic processes and not to somatic Ca 2+ oscillations (Di Castro et al, 2011 ; Álvarez-Ferradas et al, 2015 ); (ii) ATP is released by astrocytes as a mechanism for paracrine signaling in several neuropathologies, being P2YR-mediated signaling one of the main pathways for astrocyte-to-astrocyte communication in pathological conditions (Anderson et al, 2004 ; Iwabuchi and Kawahara, 2011 ; Pascual et al, 2012 ; Orellana et al, 2013 ; Delekate et al, 2014 ); and (iii) astrocytes generate Ca 2+ transients as a consequence of P2YR activation (Bowser and Khakh, 2007 ; Torres et al, 2012 ), which is also observed in pathological conditions, including epilepsy (Delekate et al, 2014 ; Álvarez-Ferradas et al, 2015 ; Ravin et al, 2016 ; Reichenbach et al, 2018 ). In addition, it has been shown that P2Y 1 R induces large and long-lasting astrocytic Ca 2+ transients that do not require action potentials for their generation (Gallagher and Salter, 2003 ; Shigetomi et al, 2018 ), which is consistent with our previous findings (Álvarez-Ferradas et al, 2015 ) and with the decrease in the frequency and percentage of STs associated with P2Y 1 R blockade in the epileptic hippocampus above described (Figure 2 ).…”